EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Ethyl Gallate Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Suppressing Inflammation and Modulating the Gut Microbiota-Intestinal Barrier Axis

Cheng Wang, Congyang Zheng, Tingting Pang, Wei Luo, Jingkun Bai, Chundi Gao, Changgang Sun, Yuanyuan Chen

Inflammation · 26.03.2026 · 49 (1)

DOI: 10.1007/s10753-026-02489-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, online erschienen am 26.03.2026. Verfasst von Cheng Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medical, Chengdu Medical College, Chengdu, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diet, High-Fat, Gastrointestinal Microbiome, Inflammation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: High-Level Scientific Research Start-up Fund of the First Affiliated Hospital of Chengdu Medical College, Sichuan Provincial Science and Technology Support Program, Health Commission of Sichuan Province Medical Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseDiet, High-FatGastrointestinal MicrobiomeInflammationGallic AcidIntestinal MucosaAnimalsMiceMaleMice, Inbred C57BLLiverAnti-Inflammatory Agents

Stichwörter der Autor:innen

Ethyl gallateGut microbiotaInflammationIntestinal barrierNon-alcoholic fatty liver disease

Substanzen

Gallic AcidAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Clinical Medical, Chengdu Medical College, Chengdu, China.
  • Department of Pharmacy, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
  • Medical School of Chinese PLA, Beijing, China.
  • School of Traditional Chinese Medicine, Shandong Second Medical University, Weifang, China.
  • School of Bioscience and Technology, Shandong Second Medical University, Weifang, 261053, China.
  • School of Traditional Chinese Medicine, Shandong Second Medical University, Weifang, China. gaochundi2017@163.com.

Förderung

  • High-Level Scientific Research Start-up Fund of the First Affiliated Hospital of Chengdu Medical College
  • Sichuan Provincial Science and Technology Support Program
  • Health Commission of Sichuan Province Medical Science and Technology Program
  • 8th Chengdu Pharmaceutical Association Pharmaceutical Research Project
  • Youth Innovation Team Development Program for Higher Education Institutions in Shandong Province
  • Project of Scientific Research and Innovation Programme of Shandong Second Medical University

Zitieren

APA

Wang, C., Zheng, C., Pang, T., Luo, W., Bai, J., Gao, C., Sun, C., & Chen, Y. (2026). Ethyl Gallate Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Suppressing Inflammation and Modulating the Gut Microbiota-Intestinal Barrier Axis. Inflammation, 49(1). https://doi.org/10.1007/s10753-026-02489-4

Vancouver

Wang C, Zheng C, Pang T, Luo W, Bai J, Gao C, et al. Ethyl Gallate Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Suppressing Inflammation and Modulating the Gut Microbiota-Intestinal Barrier Axis. Inflammation. 2026;49(1). doi:10.1007/s10753-026-02489-4

BibTeX
@article{Wang2026,
  author = {Wang, Cheng and Zheng, Congyang and Pang, Tingting and Luo, Wei and Bai, Jingkun and Gao, Chundi and Sun, Changgang and Chen, Yuanyuan},
  title = {Ethyl Gallate Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Suppressing Inflammation and Modulating the Gut Microbiota-Intestinal Barrier Axis},
  journal = {Inflammation},
  year = {2026},
  volume = {49},
  number = {1},
  doi = {10.1007/s10753-026-02489-4}
}
Kostenlos starten →